Skip to content

Investigating the Link between Vitamin D Deficiency, Anhedonia, and Cognitive Dysfunction in Adolescent Depression

Investigating the Link between Vitamin D Deficiency, Anhedonia, and Cognitive Dysfunction in Adolescent Depression

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112755
Enrollment
Unknown
Registered
2025-11-19
Start date
2025-11-20
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major Depressive Disorder

Interventions

The vitamin D sufficiency with mild-to-moderate depression group:None
The vitamin D sufficiency with severe depression group:None
Vitamin D-Sufficient/Deficient, Mild-to-Moderate Depression Group:None
Vitamin D deficiency mild to moderate depression group:None

Sponsors

Affiliated Hospital of GuiZhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 12–18 years who meet the DSM-5 criteria for a depressive episode; 2. Right-handed; 3. With more than >6 years of formal education; 4. A baseline score >= 8 on the 24-item Hamilton Depression Rating Scale (HAMD-24); 5. Provision of voluntary informed consent; 6. Serum 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] level < 30 ng/L, as defined by the assessment criteria for vitamin D deficiency established by the Endocrine Society.

Exclusion criteria

Exclusion criteria: 1. History of psychiatric or manic disorders; 2. Inability to definitively attribute the depressive symptoms to major depressive disorder rather than other conditions (e.g., substance abuse, or relevant medical conditions including epilepsy and a history of abnormal EEG); 3. Comorbid severe or unstable medical illnesses; 4. History of neurological disorders or traumatic brain injury; 5. Any other condition deemed by the investigator as inappropriate for participation in this study.

Design outcomes

Primary

MeasureTime frame
1,25-Dihydroxyvitamin D;Disease assessment (evaluated using the 24-item Hamilton Depression Rating Scale and the Self-Rating Depression Scale);Cognitive function changes;Changes in the degree of anhedonia;

Secondary

MeasureTime frame
Brain functional changes;

Countries

China

Contacts

Public ContactWang Yiming

Affiliated Hospital of GuiZhou Medical University

754603457@qq.com+86 135 1196 7666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026